- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Joanna Breitstein
Joanna Breitstein
Executive Editor
jbreitstein@advanstar.com
Joanna Breitstein is executive editor at Pharmaceutical Executive magazine, and has been with the publication since November 2000. During that time, she's interviewed countless CEOs and other pharma executives for cover stories and feature articles on all aspects of the development and commercialization of pharmaceuticals. In 2004, Joanna won a fellowship from the Kaiser Family Foundation to travel to Africa and report on AIDS drug distribution under President Bush's PEPFAR grant, resulting in a two-part series on the topic. Joanna also won a Neal Award, for excellence in business journalism, in 2002 for her cover story focusing on the coverage of diagnostics and pharmaceuticals, and a Grand Neal Award in 2001, for a cover story on patient advocacy in oncology. Before joining Pharmaceutical Executive, Joanna deepened her knowledge of the pharma industry and several treatment categories within the health and medical group at Ogilvy Public Relations Worldwide. She is also president of the international HUG Foundation, a 501c3 organization whose mission is to help needy orphans in Uganda.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start
October 30th 2024By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.
